Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Methotrexate therapy of metastatic choriocarcinoma
James F. Holland
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Methotrexate therapy of metastatic choriocarcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
High Dose
100%
Lung
100%
Gonadotropins
100%
Methotrexate
100%
Hertz
100%
Pelvis
100%
Titer
100%
Methotrexate Treatment
100%
Tumor Mass
100%
Choriocarcinoma
100%
Urinary Gonadotropins
100%
Metastatic Choriocarcinoma
100%
Medicine and Dentistry
Methotrexate
100%
Gonadotropin
100%
Choriocarcinoma
100%
Drug Megadose
50%
Neoplasm
50%
Urinary System
50%
Pelvis
50%
Lung
50%
Nursing and Health Professions
Methotrexate
100%
Gonadotropin
100%
Choriocarcinoma
100%
Drug Megadose
50%
Neoplasm
50%
Pharmacology, Toxicology and Pharmaceutical Science
Gonadotropin
100%
Methotrexate
100%
Choriocarcinoma
100%
Neoplasm
50%